A primary lung cancer patient who underwent lobectomy after one month of dual antiplatelet therapy following coronary stent deployment-Reference-Cited by-同舟云学术

A primary lung cancer patient who underwent lobectomy after one month of dual antiplatelet therapy following coronary stent deployment

Published:2022-03-15 Issue:2 Volume:36 Page:150-155
ISSN:0919-0945
Container-title:The Journal of the Japanese Association for Chest Surgery
language:en
Short-container-title:The Journal of the Japanese Association for Chest Surgery

Author:

Naruke Masao¹,Kondo Hisaya²,Ohtsuka Takashi³,Sato Michio⁴

Affiliation:

1. Department of General Thoracic Surgery, International Goodwill Hospital

2. Department of Cardiology, International Goodwill Hospital

3. Department of Surgery, Division of Thoracic Surgery, The Jikei University School of Medicine

4. Department of Surgery, International Goodwill Hospital

Publisher

Japanese Association for Chest Surgery

Link

https://www.jstage.jst.go.jp/article/jacsurg/36/2/36_150/_pdf

Reference25 articles.

1. 1. 米井彰洋, 森山裕一. 経皮的冠動脈形成術に引き続く, 抗血小板薬2剤併用療法の後, アスピリン単剤継続下に手術を行った原発性肺癌の1例. 日呼外会誌 2020; 34: 358-63.

2. 2. 木村一雄，中村正人，石原正治，大塚文之，木村剛，上妻謙，他．2020年JCSガイドラインフォーカスアップデート版冠動脈疾患患者における抗血栓療法［Internet］東京：日本循環器学会［Updated：2020 Mar.13 Cited：2021 Mar.29］Available from：https://www.j-circ.or.jp/cms/wp-content/uploads/2020/04/JCS2020_Kimura_Nakamura.pdf.

3. 3. Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: A pooled analysis of individual-patient datasets from clinical trials. Lancet 2017; 389: 1025-34.

4. 4. Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, et al. Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA 2016; 315: 1735-49.

5. 5. Natsuaki M, Morimoto T, Yamaji K, Watanabe H, Yoshikawa Y, Shiomi H, et al. CREDO-Kyoto PCI/CABG Registry Cohort 2, RESET, and NEXT trial investigators. Prediction of thrombotic and bleeding events after percutaneous coronary intervention: CREDO-Kyoto thrombotic and bleeding risk scores. J Am Heart Assoc 2018; 7: e008708.